Terms: = Kidney tumors AND NTRK3, TRKC, 4916, ENSG00000140538, Q16288, gp145 trkC
44 results:
1. Report and follow-up on two new patients with congenital mesoblastic nephroma.
Serra G; Cimador M; Giuffrè M; Insinga V; Montante C; Pensabene M; Piro E; Salerno S; Schierz IAM; Corsello G
Ital J Pediatr; 2023 Sep; 49(1):124. PubMed ID: 37726782
[TBL] [Abstract] [Full Text] [Related]
2. Congenital mesoblastic nephroma: review of current management and outcomes in a single centre.
Rayner J; Vinycomb T; Wanaguru D; Jiwane A
ANZ J Surg; 2023 Apr; 93(4):1008-1011. PubMed ID: 36382605
[TBL] [Abstract] [Full Text] [Related]
3. Whole-exome sequencing identified mutational profiles of urothelial carcinoma post kidney transplantation.
Lim LM; Chung WY; Hwang DY; Yu CC; Ke HL; Liang PI; Lin TW; Cheng SM; Huang AM; Kuo HT
J Transl Med; 2022 Jul; 20(1):324. PubMed ID: 35864526
[TBL] [Abstract] [Full Text] [Related]
4. A novel ETV6-ntrk3 gene fusion in primary renal fibrosarcoma.
Jiang H
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4705-4708. PubMed ID: 35856362
[TBL] [Abstract] [Full Text] [Related]
5. Infantile fibrosarcoma with an EGFR kinase domain duplication: Underlining a close relationship with congenital mesoblastic nephroma and highlighting a similar morphological spectrum.
van Spronsen R; Kester LA; Knops RRG; van de Sande MAJ; van Leenders GJLH; de Laat PCJ; Stortelder E; Korpershoek E; van Noesel MM; Meister MT; Koerkamp MJAG; de Graaf N; Giovannoni I; Tops BBJ; de Krijger RR; Ter Horst SAJ; Flucke U; Alaggio R; Hiemcke-Jiwa LS
Ann Diagn Pathol; 2022 Apr; 57():151885. PubMed ID: 35032896
[TBL] [Abstract] [Full Text] [Related]
6. Mesenchymal neoplasms with NTRK and other kinase gene alterations.
Davis JL; Al-Ibraheemi A; Rudzinski ER; Surrey LF
Histopathology; 2022 Jan; 80(1):4-18. PubMed ID: 34958503
[TBL] [Abstract] [Full Text] [Related]
7. NTRK-Rearranged soft tissue neoplasms: A review of evolving diagnostic entities and algorithmic detection methods.
Surrey LF; Davis JL
Cancer Genet; 2022 Jan; 260-261():6-13. PubMed ID: 34794069
[TBL] [Abstract] [Full Text] [Related]
8. An unusual fusion gene EML4-ALK in a patient with congenital mesoblastic nephroma.
Misove A; Vicha A; Zapotocky M; Malis J; Balko J; Nemeckova T; Szabova J; Kyncl M; Novakova-Kodetova D; Stolova L; Jencova P; Broz P; Krskova L
Genes Chromosomes Cancer; 2021 Dec; 60(12):837-840. PubMed ID: 34378283
[TBL] [Abstract] [Full Text] [Related]
9. Second Report of
Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
[TBL] [Abstract] [Full Text] [Related]
10. Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma.
Penning AJ; Al-Ibraheemi A; Michal M; Larsen BT; Cho SJ; Lockwood CM; Paulson VA; Liu YJ; Plank L; Fritchie K; Beadling C; Neff TL; Corless CL; Rudzinski ER; Davis JL
Mod Pathol; 2021 Aug; 34(8):1530-1540. PubMed ID: 33850302
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric Renal tumors: Updates in the Molecular Era.
Treece AL
Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
[TBL] [Abstract] [Full Text] [Related]
12. Adjuvant Maintenance Larotrectinib Therapy in 2 Children With NTRK Fusion-positive High-grade Cancers.
Carter-Febres M; Schneller N; Fair D; Solomon D; Perry A; Roy A; Linscott L; Alashari M; Kestle JR; Bruggers CS
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e987-e990. PubMed ID: 33093355
[TBL] [Abstract] [Full Text] [Related]
13. KANK1-ntrk3 fusions define a subset of BRAF mutation negative renal metanephric adenomas.
Catic A; Kurtovic-Kozaric A; Sophian A; Mazur L; Skenderi F; Hes O; Rohan S; Rakheja D; Kogan J; Pins MR
BMC Med Genet; 2020 Oct; 21(1):202. PubMed ID: 33046021
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological characteristics of NTRK-rearranged mesenchymal tumors in childhood].
Yin MZ; Ma J; He Q; Shen P; Chen JF; Jin XT; Zhang ZD; Kuick CH; Chen HY; Ng EHQ; Aw SJ; Chang KTE
Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):675-680. PubMed ID: 32610377
[No Abstract] [Full Text] [Related]
15. Congenital mesoblastic nephroma is characterised by kinase mutations including EGFR internal tandem duplications, the ETV6-ntrk3 fusion, and the rare KLHL7-BRAF fusion.
Zhao M; Yin M; Kuick CH; Chen H; Aw SJ; Merchant K; Ng EHQ; Gunaratne S; Loh AHP; Gu W; Tang H; Chang KTE
Histopathology; 2020 Oct; 77(4):611-621. PubMed ID: 32590884
[TBL] [Abstract] [Full Text] [Related]
16. ntrk3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations.
Kao YC; Sung YS; Argani P; Swanson D; Alaggio R; Tap W; Wexler L; Dickson BC; Antonescu CR
Mod Pathol; 2020 Jul; 33(7):1341-1349. PubMed ID: 32034283
[TBL] [Abstract] [Full Text] [Related]
17. Unusual Case of Concurrent Retroperitoneal Congenital Infantile Fibrosarcoma and Cellular Type Congenital Mesoblastic Nephroma.
Monsereenusorn C; Supakul N; Satayasoontorn K; Traivaree C; Rujkijyanont P
J Pediatr Hematol Oncol; 2020 Nov; 42(8):e801-e806. PubMed ID: 31343481
[TBL] [Abstract] [Full Text] [Related]
18. Sex specific associations in genome wide association analysis of renal cell carcinoma.
Laskar RS; Muller DC; Li P; Machiela MJ; Ye Y; Gaborieau V; Foll M; Hofmann JN; Colli L; Sampson JN; Wang Z; Bacq-Daian D; Boland A; Abedi-Ardekani B; Durand G; Le Calvez-Kelm F; Robinot N; Blanche H; Prokhortchouk E; Skryabin KG; Burdett L; Yeager M; Radojevic-Skodric S; Savic S; Foretova L; Holcatova I; Janout V; Mates D; Rascu S; Mukeria A; Zaridze D; Bencko V; Cybulski C; Fabianova E; Jinga V; Lissowska J; Lubinski J; Navratilova M; Rudnai P; Świątkowska B; Benhamou S; Cancel-Tassin G; Cussenot O; Trichopoulou A; Riboli E; Overvad K; Panico S; Ljungberg B; Sitaram RT; Giles GG; Milne RL; Severi G; Bruinsma F; Fletcher T; Koppova K; Larsson SC; Wolk A; Banks RE; Selby PJ; Easton DF; Pharoah P; Andreotti G; Beane Freeman LE; Koutros S; Albanes D; Männistö S; Weinstein S; Clark PE; Edwards TL; Lipworth L; Carol H; Freedman ML; Pomerantz MM; Cho E; Kraft P; Preston MA; Wilson KM; Michael Gaziano J; Sesso HD; Black A; Freedman ND; Huang WY; Anema JG; Kahnoski RJ; Lane BR; Noyes SL; Petillo D; Teh BT; Peters U; White E; Anderson GL; Johnson L; Luo J; Chow WH; Moore LE; Choueiri TK; Wood C; Johansson M; McKay JD; Brown KM; Rothman N; Lathrop MG; Deleuze JF; Wu X; Brennan P; Chanock SJ; Purdue MP; Scelo G
Eur J Hum Genet; 2019 Oct; 27(10):1589-1598. PubMed ID: 31231134
[TBL] [Abstract] [Full Text] [Related]
19. Screening for NTRK-rearranged tumors Using Immunohistochemistry: Comparison of 2 Different pan-TRK Clones in Melanoma Samples.
Bourhis A; Redoulez G; Quintin-Roué I; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2020 Mar; 28(3):194-196. PubMed ID: 30920961
[TBL] [Abstract] [Full Text] [Related]
20. Pan-Trk Immunohistochemistry Identifies NTRK Rearrangements in Pediatric Mesenchymal tumors.
Rudzinski ER; Lockwood CM; Stohr BA; Vargas SO; Sheridan R; Black JO; Rajaram V; Laetsch TW; Davis JL
Am J Surg Pathol; 2018 Jul; 42(7):927-935. PubMed ID: 29683818
[TBL] [Abstract] [Full Text] [Related]
[Next]
